
Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients
Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients
Dyne Therapeutics Announces Positive Initial Clinical Data from ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients
Read Astellas community letter below:
Solid Biosciences Announces IND Clearance by FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
The silver screen has been featuring more and more stories about people with disabilities, whether it be developmental, physical, or mental. With more representation in popular culture, comes more understanding […]
Volunteering within our community helps us lift everyone around us while making us feel good about our impact in the world. It’s something that is open to anyone, regardless of […]
Halloween is a time of year for candy, trick-or-treating, and of course, everyone’s favorite, dressing up as iconic Hollywood, video game, and pop culture characters. At first thought, donning a […]
Tips for Success in the Workplace with Duchenne.
Doug Levine, PT, a physical therapist instructor with CureDuchenne, and Kerry Johnson, senior director of community engagement, visited India in February to educate physical therapists, doctors, physical and occupational therapy […]
Hawken Miller, who brings his journalism experience and the perspective of having Duchenne himself, writes about how he tries to focus on the things that he can do rather than what he can’t in this CureDuchenne blog. It helps him live a more purposeful and joyful life.